{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:13:45Z","timestamp":1780618425458,"version":"3.54.1"},"reference-count":36,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2023423002"],"award-info":[{"award-number":["H2023423002"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["246W2501D"],"award-info":[{"award-number":["246W2501D"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Plan Project of Hebei Province","award":["H2023423002"],"award-info":[{"award-number":["H2023423002"]}]},{"name":"Science and Technology Plan Project of Hebei Province","award":["246W2501D"],"award-info":[{"award-number":["246W2501D"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Chronic atrophic gastritis precancerous lesions (PL-CAG) are characterized by the atrophy of gastric mucosal glands, often accompanied by intestinal metaplasia or dysplasia. Timely intervention and treatment can effectively reverse its malignant progression and prevent the onset of gastric cancer. Bombyx Batryticatus (BB) exhibits a range of pharmacological effects, including anticoagulation, antiepileptic properties, anticancer activity, and antibacterial effects. However, the pharmacological basis and mechanisms underlying BB\u2019s efficacy in treating PL-CAG remain unclear. Methods: A three-factor modeling approach was implemented to develop a rat PL-CAG model, while the MNNG-induced PLGC (precancerous lesions of gastric cancer) cell model was served as a cell PL-CAG model. UPLC-QE-Orbitrap-MS\/MS (Ultra performance liquid chromatography-quadrupole-electrostatic field orbital trap high-resolution mass spectrometry) was utilized to perform an in-depth analysis of the components in the plasma extract of BB. Leveraging network pharmacology, molecular docking analyses, and experimental validation, we initially elucidated the potential mechanisms through which BB mediates its therapeutic effects on PL-CAG at both in vivo and in vitro levels. Results: Prototype compounds of 42 blood-entering components were identified by UPLC-QE-Orbitrap-MS\/MS analysis. Network pharmacology analysis and molecular docking studies indicate that the core targets are primarily enriched in the PI3K-Akt signaling pathway, and the key components, including Nepitrin, Quercetin 3-O-neohesperidoside, Rutin, and others, exhibited stable docking conformations with the first eleven pivotal targets. Both in vivo and in vitro experiments validated that BB may effectively treat PL-CAG via modulation of the PI3K-Akt signaling pathway. Conclusions: The therapeutic efficacy of BB in the management of PL-CAG may be achieved through the synergistic interaction of multiple components and targets, which may be more closely related to the inhibition of the PI3K\/AKT signaling pathway. This approach will establish a solid experimental foundation and provide essential data for the clinical application of BB in treating PL-CAG, while also facilitating further research initiatives.<\/jats:p>","DOI":"10.3390\/ph18060791","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:39:36Z","timestamp":1748205576000},"page":"791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Therapeutic Potential of Bombyx Batryticatus for Chronic Atrophic Gastritis Precancerous Lesions via the PI3K\/AKT\/mTOR Pathway Based on Network Pharmacology of Blood-Entering Components"],"prefix":"10.3390","volume":"18","author":[{"given":"Xiaojie","family":"Wang","sequence":"first","affiliation":[{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Chang","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Feng","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyue","family":"Wang","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang 050200, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019","volume":"51","author":"Libanio","year":"2019","journal-title":"Endoscopy"},{"key":"ref_3","first-page":"3269","article-title":"Research progress on processing history, chemical composition and pharmacological action of Bombyx batryticatus","volume":"48","author":"Qiu","year":"2023","journal-title":"Chin. J. Tradit. Chin. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hu, M., Yu, Z., Wang, J., Fan, W., Liu, Y., Li, J., Xiao, H., Li, Y., Peng, W., and Wu, C. (2017). Traditional Uses, Origins, Chemistry and Pharmacology of Bombyx batryticatus: A Review. Molecules, 22.","DOI":"10.3390\/molecules22101779"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"113549","DOI":"10.1016\/j.jep.2020.113549","article-title":"Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan","volume":"268","author":"Liu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_6","first-page":"2312","article-title":"Application of UPLC-Q-Exactive Orbitrap MS technique in the analysis of traditional Chinese medicine","volume":"43","author":"Zeng","year":"2020","journal-title":"Tradit. Chin. Med. Mater."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(75)90498-5","article-title":"A model for gastric cancer epidemiology","volume":"2","author":"Correa","year":"1975","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse Effects Associated With Proton Pump Inhibitors","volume":"176","author":"Schoenfeld","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/1568026615666150813144003","article-title":"Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer\u2019s Disease Therapy","volume":"16","author":"Li","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_10","first-page":"150","article-title":"Research progress on the chemical composition and pharmacological effects of Bombyx batryticatus in traditional Chinese medicine and Western medicine","volume":"41","author":"Nan","year":"2023","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"ref_11","first-page":"93","article-title":"Experience of Professor Liuxiang Huang in Treating Chronic Atrophic Gastritis","volume":"17","author":"Wen","year":"2021","journal-title":"Tradit. Med. Asia-Pac. Reg."},{"key":"ref_12","first-page":"1237","article-title":"Professor Li Diangui\u2019s Experience in Treating Stomach and Intestinal Diseases Based on the Theory of Turbid Toxins and Using Danggui Shaoyao Powder","volume":"44","author":"Huang","year":"2022","journal-title":"Hebei J. TCM"},{"key":"ref_13","first-page":"256","article-title":"Famous Chinese TCM doctor Shen Shuwen uses animal-based traditional Chinese medicine to treat gastric cancer precursor conditions in clinical practice","volume":"45","author":"Song","year":"2024","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1158\/1055-9965.EPI-21-1328","article-title":"Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data","volume":"31","author":"In","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33265","DOI":"10.1074\/jbc.M707090200","article-title":"Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation","volume":"282","author":"Zavros","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105933","DOI":"10.1016\/j.micpath.2022.105933","article-title":"IL-1beta, an important cytokine affecting Helicobacter pylori-mediated gastric carcinogenesis","volume":"174","author":"Xiaoyan","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_17","first-page":"cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bent, R., Moll, L., Grabbe, S., and Bros, M. (2018). Interleukin-1 Beta-A Friend or Foe in Malignancies?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082155"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5958429","DOI":"10.1155\/2017\/5958429","article-title":"Proinflammatory Cytokines IL-6 and TNF-alpha Increased Telomerase Activity through NF-kappaB\/STAT1\/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells","volume":"2017","author":"Chung","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Valverde, M., and Sanchez-Brito, A. (2021). Sustained Activation of TNFalpha-Induced DNA Damage Response in Newly Differentiated Adipocytes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910548"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tanaka, T., Narazaki, M., and Kishimoto, T. (2018). Interleukin (IL-6) Immunotherapy. Cold Spring Harb. Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a028456"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, X., Pearce, R., Omenn, G.S., and Zhang, Y. (2021). Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137060"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"McKenna, M., Balasuriya, N., Zhong, S., Li, S.S., and O\u2019Donoghue, P. (2020). Phospho-Form Specific Substrates of Protein Kinase B (AKT1). Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.619252"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Linde-Garelli, K.Y., and Rogala, K.B. (2023). Structural mechanisms of the mTOR pathway. Curr. Opin. Struct. Biol., 82.","DOI":"10.1016\/j.sbi.2023.102663"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105293","DOI":"10.1016\/j.tiv.2021.105293","article-title":"Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells","volume":"79","author":"Singh","year":"2022","journal-title":"Toxicol. In Vitro"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.7150\/jca.51253","article-title":"POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK\/AKT\/mTOR pathway","volume":"12","author":"Jia","year":"2021","journal-title":"J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ban, Y., Zou, Y., Liu, Y., Lee, S.B., Bednarczyk, R.B., Sheng, J., Cao, Y., Wong, S.T.C., and Gao, D. (2024). Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer. bioRxiv.","DOI":"10.7554\/eLife.89486.2"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41467-023-37161-0","article-title":"YBX1 integration of oncogenic PI3K\/mTOR signalling regulates the fitness of malignant epithelial cells","volume":"14","author":"Bai","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"115885","DOI":"10.1016\/j.jep.2022.115885","article-title":"Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt\/beta-catenin signaling pathway","volume":"302","author":"Liao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","article-title":"E-cadherin in contact inhibition and cancer","volume":"37","author":"Mendonsa","year":"2018","journal-title":"Oncogene"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cao, Z.Q., Wang, Z., and Leng, P. (2019). Aberrant N-cadherin expression in cancer. Biomed. Pharmacother., 118.","DOI":"10.1016\/j.biopha.2019.109320"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13020-021-00445-y","article-title":"Determination of the protective effects of Hua-Zhuo-Jie-Du in chronic atrophic gastritis by regulating intestinal microbiota and metabolites: Combination of liquid chromatograph mass spectrometer metabolic profiling and 16S rRNA gene sequencing","volume":"16","author":"Zhou","year":"2021","journal-title":"Chin. Med."},{"key":"ref_35","first-page":"1069","article-title":"Equivalent dose conversion between animals and between animals and humans in pharmacological experiments","volume":"9","author":"Huang","year":"2004","journal-title":"Des. Stat. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"116342","DOI":"10.1016\/j.jep.2023.116342","article-title":"Mass spectrometry-based metabolomics reveal Dendrobium huoshanense polysaccharide effects and potential mechanism of N-methyl-N\u2019-nitro-N-nitrosoguanidine -induced damage in GES-1 cells","volume":"310","author":"Xie","year":"2023","journal-title":"J. Ethnopharmacol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/6\/791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:40:06Z","timestamp":1760031606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/6\/791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ph18060791"],"URL":"https:\/\/doi.org\/10.3390\/ph18060791","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]}}}